{"denoms":[{"counts":[{"groupId":"BG000","value":"74"},{"groupId":"BG001","value":"75"},{"groupId":"BG002","value":"24"},{"groupId":"BG003","value":"23"},{"groupId":"BG004","value":"196"}],"units":"Participants"}],"groups":[{"description":"Non-treatment-induced patients receive azacitidine (50 mg/m2) subcutaneously once daily on days 1-10 in a 28-day cycle.","id":"BG000","title":"Arm A (Azacitidine; Non-treatment-induced Cohort)"},{"description":"Non-treatment-induced patients receive azacitidine as in arm A and oral entinostat (4 mg/m2) on days 3 and 10 of each 28-day cycle.","id":"BG001","title":"Arm B (Azacitidine + Entinostat; Non-treatment-induced Cohort)"},{"description":"Treatment-induced patients receive azacitidine (50 mg/m2) subcutaneously once daily on days 1-10 in a 28-day cycle.","id":"BG002","title":"Arm A (Azacitidine; Treatment-induced Cohort)"},{"description":"Treatment-induced patients receive azacitidine as in arm A and oral entinostat (4 mg/m2) on days 3 and 10 of each 28-day cycle.","id":"BG003","title":"Arm B (Azacitidine + Entinostat; Treatment-induced Cohort)"},{"description":"Total of all reporting groups","id":"BG004","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"25","upperLimit":"87","value":"72"},{"groupId":"BG001","lowerLimit":"30","upperLimit":"86","value":"72"},{"groupId":"BG002","lowerLimit":"54","upperLimit":"83","value":"68"},{"groupId":"BG003","lowerLimit":"39","upperLimit":"81","value":"71"},{"groupId":"BG004","lowerLimit":"25","upperLimit":"87","value":"71"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"24"},{"groupId":"BG001","value":"23"},{"groupId":"BG002","value":"15"},{"groupId":"BG003","value":"11"},{"groupId":"BG004","value":"73"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"50"},{"groupId":"BG001","value":"52"},{"groupId":"BG002","value":"9"},{"groupId":"BG003","value":"12"},{"groupId":"BG004","value":"123"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Gender","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"74"},{"groupId":"BG001","value":"75"},{"groupId":"BG002","value":"24"},{"groupId":"BG003","value":"23"},{"groupId":"BG004","value":"196"}]}],"title":"United States"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"}],"populationDescription":"All treated patients were included in the analysis."}